Area of research
Oncology · Molecular Biology
Research interest
Research interests include Medicine, Disintegrin, Triple-negative breast cancer, Cancer research, Metastasis, and Angiogenesis.
MAT2A inhibitor AG-270/S095033 in patients with advanced malignancies: a phase I trial
Lung injury associated with mTOR inhibitors (sirolimus and everolimus).
PubMed 2014cited by 1position: middle
ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis